09/01/2020
11:25 AM | Avoro Capital Advisors LLC (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G
| |
08/28/2020
10:15 AM | CymaBay Therapeutics (Filer)
| Form CT ORDER
| |
08/10/2020
3:02 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2020
9:00 AM | Aghazadeh Behzad (Reporting)
Avoro Capital Advisors LLC (Reporting)
CymaBay Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/14/2020
3:13 PM | CymaBay Therapeutics (Filer)
| Form 424B5
| |
07/14/2020
3:12 PM | CymaBay Therapeutics (Filer)
| Form 424B5
| |
07/13/2020
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT
| |
05/19/2020
4:23 PM | CymaBay Therapeutics (Issuer)
von Emster Kurt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:22 PM | CymaBay Therapeutics (Issuer)
TRUEX PAUL F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:20 PM | CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/19/2020
4:19 PM | CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:17 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
4:16 PM | CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2020
8:00 AM | CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
| Form SC 13D/A
| |
05/11/2020
4:15 PM | CymaBay Therapeutics (Filer)
| Form DEFA14A
| |
05/11/2020
3:08 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2020
3:02 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2020
1:50 PM | CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
| Form PRRN14A
| |
04/27/2020
3:42 PM | CymaBay Therapeutics (Subject)
| Form PREC14A
| |
04/24/2020
3:50 PM | CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
| Form PREC14A
| |
03/13/2020
4:29 PM | CymaBay Therapeutics (Filer)
| Form DEFA14A
| |
02/14/2020
4:02 PM | CymaBay Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2020
3:26 PM | CymaBay Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A
| |
02/14/2020
12:13 PM | CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
| Form SC 13D/A
| |
02/14/2020
9:21 AM | Avoro Capital Advisors LLC (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G
| |
02/11/2020
3:44 PM | CymaBay Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
02/05/2020
10:45 AM | BlackRock Inc. (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A
| |
01/29/2020
3:19 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2020
3:46 PM | CymaBay Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A
| |
12/19/2019
4:25 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2019
1:32 PM | CymaBay Therapeutics (Subject)
Newtyn Management, LLC (Filed by)
| Form SC 13G
| |
12/12/2019
4:04 PM | CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
| Form SC 13D
| |
10/15/2019
7:20 AM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2019
7:56 AM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2019
3:44 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
3:03 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019
6:01 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
5:57 PM | CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2019
4:04 PM | CymaBay Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G
| |
06/14/2019
3:05 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2019
3:02 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2019
3:07 PM | CymaBay Therapeutics (Filer)
| Form DEF 14A
| |
03/11/2019
7:30 AM | CymaBay Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G
| |
03/06/2019
3:27 PM | CymaBay Therapeutics (Filer)
| Form 424B5
| |
03/05/2019
3:51 PM | CymaBay Therapeutics (Filer)
| Form 424B5
| |
02/28/2019
3:07 PM | CymaBay Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2019
3:02 PM | CymaBay Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2019
3:29 PM | BAKER BROS. ADVISORS LP (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2019
12:51 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2019
12:00 PM | CymaBay Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
| Form SC 13G/A
| |
02/13/2019
10:50 AM | CymaBay Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
02/11/2019
11:15 PM | CymaBay Therapeutics (Filer)
| Form EFFECT
| |
02/08/2019
7:21 PM | CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2019
4:07 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2019
4:30 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:29 PM | CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:29 PM | CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:28 PM | Boudes Pol F (Reporting)
CymaBay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:27 PM | CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:26 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:24 PM | CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:23 PM | CymaBay Therapeutics (Issuer)
Weiland Robert J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:22 PM | CymaBay Therapeutics (Issuer)
TRUEX PAUL F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:22 PM | CymaBay Therapeutics (Issuer)
STEIN EVAN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:21 PM | CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:20 PM | CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:19 PM | Booth Robert F. (Reporting)
CymaBay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
4:15 PM | CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/31/2019
4:04 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
3:06 PM | CymaBay Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/21/2018
4:11 PM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2018
3:18 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2018
3:02 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
7:00 AM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2018
5:21 AM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2018
6:24 PM | CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2018
4:02 PM | CymaBay Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/09/2018
3:02 PM | CymaBay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2018
5:05 AM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2018
8:00 AM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
8:59 AM | CymaBay Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
06/11/2018
7:42 AM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4/A
| |
06/07/2018
6:30 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2018
3:11 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2018
7:08 AM | CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/20/2018
3:26 PM | CymaBay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2018
3:24 PM | CymaBay Therapeutics (Filer)
| Form DEFA14A
| |
04/20/2018
3:19 PM | CymaBay Therapeutics (Filer)
| Form DEF 14A
| |
03/23/2018
3:56 PM | CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2018
3:22 PM | CymaBay Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/15/2018
3:17 PM | CymaBay Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2018
3:19 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2018
3:08 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2018
1:44 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4/A
| |
02/15/2018
3:12 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2018
2:02 PM | Abingworth LLP (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2018
3:19 PM | BAKER BROS. ADVISORS LP (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G
| |
02/13/2018
2:45 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
CymaBay Therapeutics (Subject)
| Form SC 13G/A
| |
02/13/2018
11:28 AM | CymaBay Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
| Form SC 13G/A
| |
02/12/2018
3:09 PM | CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
